Profil bibliographique

Hozumi Shimokawa

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

32Publications signalées

43Citations signalées

3Affiliations récentes

Les institutions déclarées

Hamanomachi Hospital Kyushu Hospital Japan Community Healthcare Organization

Les domaines associés

Pancreatic and Hepatic Oncology ResearchCholangiocarcinoma and Gallbladder Cancer StudiesColorectal Cancer Treatments and StudiesCancer Genomics and DiagnosticsCancer therapeutics and mechanisms

Les publications récentes

Accès ouvert 2026 article OpenAlex

Relationship between initial dose, dose intensity, and survival in unresectable pancreatic cancer treated with nanoliposomal irinotecan, fluorouracil, and folinic acid

Yujiro Ueda, Hiroki Taguchi, Mototsugu Shimokawa, Taiga Otsuka et autres

jp (code pays fourni par la source)

0 citations Scientific Reports

2025 article OpenAlex

Nanoliposomal Irinotecan With Fluorouracil and Folinic Acid in Older Versus Younger Patients With Unresectable Pancreatic Cancer: The Multicenter NAPOLEON‐2 Study

Atsuko Kakihara, Shigeyuki Takeshita, Mototsugu Shimokawa, Taiga Otsuka et autres

jp (code pays fourni par la source)

0 citations Asia-Pacific Journal of Clinical Oncology

Accès ouvert 2025 article OpenAlex

Impact of prior chemotherapy on nanoliposomal irinotecan with fluorouracil and folinic acid for unresectable pancreatic cancer: a retrospective analysis of data from the multicenter NAPOLEON-2 study

Tomomi Koike, Yasunori Kawaguchi, Mototsugu Shimokawa, Taiga Otsuka et autres

jp (code pays fourni par la source)

0 citations Therapeutic Advances in Medical Oncology

Accès ouvert 2025 article OpenAlex

Impact of biliary drainage for unresectable pancreatic cancer treated with nanoliposomal irinotecan with fluorouracil and folinic acid: retrospective results from the NAPOLEON-2 study

Kazuo Nishikawa, Taiga Otsuka, Mototsugu Shimokawa, Takashi Inagaki et autres

jp (code pays fourni par la source)

1 citation BMC Cancer

2025 article OpenAlex

Chemotherapy‐induced neutropenia predicts short‐term outcome of patients with pancreatic cancer treated with nanoliposomal irinotecan, fluorouracil, and folinic acid

Tomonori Araki, Tsuyoshi Shirakawa, Mototsugu Shimokawa, Taiga Otsuka et autres

jp (code pays fourni par la source)

1 citation International Journal of Cancer

Accès ouvert 2025 article OpenAlex

Efficacy of third-line chemotherapy following nanoliposomal irinotecan combined with fluorouracil and folinic acid as second-line treatment for unresectable pancreatic cancer

Keisuke Miwa, Reina Kawasaki, Mototsugu Shimokawa, Taiga Otsuka et autres

jp, gr (code pays fourni par la source)

2 citations Frontiers in Oncology

Accès ouvert 2025 preprint OpenAlex

Impact of biliary drainage for unresectable pancreatic cancer treated with nanoliposomal irinotecan with fluorouracil and folinic acid: retrospective results from the NAPOLEON-2 study

Kazuo Nishikawa, Taiga Otsuka, Mototsugu Shimokawa, Takashi Inagaki et autres

jp, gr (code pays fourni par la source)

0 citations Research Square

Accès ouvert 2025 article OpenAlex

Relationship between neutropenia caused by nanoliposomal irinotecan/fluorouracil/leucovorin and treatment outcomes in the NAPOLEON-2 study (NN-2301)

Tomonori Araki, Yuki Sonoda, Mototsugu Shimokawa, Taiga Otsuka et autres

jp, us (code pays fourni par la source)

1 citation Scientific Reports

Accès ouvert 2025 conference-abstract OpenAlex

Real-world evidence of nanoliposomal irinotecan and fluorouracil with folinic acid in patients with unresectable or recurrent pancreatic cancer: Final results of a multicenter observational study.

Yudai Shinohara, Tsuyoshi Shirakawa, Mototsugu Shimokawa, Taiga Otsuka et autres

jp (code pays fourni par la source)

0 citations Journal of Clinical Oncology

Accès ouvert 2025 conference-abstract OpenAlex

A real-world prospective analysis of the relationship between nanoliposomal irinotecan and fluorouracil with folinic acid and neutropenia in patients with pancreatic cancer (NAPOLEON-2 study, NN-2401).

Tsuyoshi Shirakawa, Tomonori Araki, Mototsugu Shimokawa, Taiga Otsuka et autres

jp (code pays fourni par la source)

0 citations Journal of Clinical Oncology

Accès ouvert 2025 article OpenAlex

Comparison of inflammatory markers before and after nanoliposomal irinotecan and fluorouracil with folic acid in patients with pancreatic cancer: results from the NAPOLEON-2 study (NN-2302)

Tomonori Araki, Kohei Hayashi, Mototsugu Shimokawa, Taiga Otsuka et autres

jp (code pays fourni par la source)

2 citations Therapeutic Advances in Medical Oncology

2024 article OpenAlex

Real-World Analysis of the Correlation between Overall Survival and Progression-Free Survival in Advanced Pancreatic Cancer: Results of NAPOLEON-1 and 2 Studies

Tomonori Araki, Machiko Kawahira, Mototsugu Shimokawa, Taiga Otsuka et autres

jp (code pays fourni par la source)

1 citation Oncology

Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.